136 related articles for article (PubMed ID: 12794422)
1. Acute phase modulation of systemic insulin-like growth factor-1 and its binding proteins after major burn injuries.
Nedelec B; de Oliveira A; Garrel DR
Crit Care Med; 2003 Jun; 31(6):1794-801. PubMed ID: 12794422
[TBL] [Abstract][Full Text] [Related]
2. Modulation of systemic insulin-like growth factor-1 and its binding proteins after major burn injuries.
Ghahary A
Crit Care Med; 2003 Jun; 31(6):1879-80. PubMed ID: 12794443
[No Abstract] [Full Text] [Related]
3. Extended hypermetabolic response of the liver in severely burned pediatric patients.
Jeschke MG; Barrow RE; Herndon DN
Arch Surg; 2004 Jun; 139(6):641-7. PubMed ID: 15197091
[TBL] [Abstract][Full Text] [Related]
4. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
[TBL] [Abstract][Full Text] [Related]
5. The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes.
Hedman CA; Frystyk J; Fridell K; Jönsson A; Flyvbjerg A; Lindström T; Arnqvist HJ
Growth Horm IGF Res; 2005 Aug; 15(4):304-10. PubMed ID: 16054412
[TBL] [Abstract][Full Text] [Related]
6. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
8. Depletion of circulating insulin-like growth factor binding protein 3 after open surgery is associated with high interleukin-6 levels.
Kirman I; Poltaratskaia N; Cekic V; Forde KA; Ansari P; Boulay C; Whelan RL
Dis Colon Rectum; 2004 Jun; 47(6):911-7; discussion 917-8. PubMed ID: 15085435
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I/insulin-like growth factor binding protein-3 alters lymphocyte responsiveness following severe burn.
Wolf SE; Woodside KJ; Ramirez RJ; Kobayashi M; Suzuki F; Herndon DN
J Surg Res; 2004 Apr; 117(2):255-61. PubMed ID: 15047131
[TBL] [Abstract][Full Text] [Related]
10. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
11. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the insulin-like growth factor system by insulin in burn patients.
Lang CH; Fan J; Frost RA; Gelato MC; Sakurai Y; Herndon DN; Wolfe RR
J Clin Endocrinol Metab; 1996 Jul; 81(7):2474-80. PubMed ID: 8675563
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum insulin-like growth factor-I in burn patients: relationship with serum insulin-like growth factor binding protein-3 proteolysis and the influence of lipid composition in nutritional support.
Abribat T; Nedelec B; Jobin N; Garrel DR
Crit Care Med; 2000 Jul; 28(7):2366-72. PubMed ID: 10921566
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model.
An Y; Xiao YB
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):342-50. PubMed ID: 17662771
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
16. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
Ahmed RL; Thomas W; Schmitz KH
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
[TBL] [Abstract][Full Text] [Related]
17. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
19. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
20. [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects].
Chai J; Hao D; Wu Y; Shen C; Guo Z; Sheng Z
Zhonghua Wai Ke Za Zhi; 2002 Feb; 40(2):107-11. PubMed ID: 11955392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
